| Source NDC Code |
|
Target HCPCS Code |
50242-0245-01
PHESGO 1,200-600MG-30,000 U
|
⇄
|
C9399
Unclassified Drugs or Biologicals
|
| Detail Information |
| Relationship Start Date |
10/01/2020 |
| Relationship End Date |
12/31/2020 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
50242-0245-01
PHESGO 1,200-600MG-30,000 U
|
⇄
|
J9316
Pertuzu, trastuzu, 10 mg
|
| Detail Information |
| Relationship Start Date |
01/03/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
50242-0245-01
PHESGO 1,200-600MG-30,000 U
|
⇄
|
J9999
NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS
|
| Detail Information |
| Relationship Start Date |
10/01/2020 |
| Relationship End Date |
12/31/2020 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
50242-0245-01
Phesgo
|
⇄
|
J9316
Pertuzu, trastuzu, 10 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|